Name
Chamberlain University
NR-293: Pharmacology for Nursing Practice
Prof. Name
Date
The focus of this medical teaching plan brochure is Xtampza ER Oxycodone, a narcotic analgesic. Oxycodone is primarily intended for individuals experiencing pain. It functions by binding to opiate receptors in the central nervous system (CNS), altering both the perception and response to painful stimuli while inducing generalized CNS depression (Vallerand, Sanoski, & Quiring, 2019). The therapeutic goal of oxycodone is to reduce pain levels effectively. Pediatric patients may also be prescribed oxycodone at lower doses, specifically 0.05–0.15 mg/kg every 4–6 hours as needed (Vallerand, Sanoski, & Quiring, 2019). This brochure aims to inform users about the medication’s details, including drug classification, mechanism of action, administration and dosage guidelines, potential drug interactions, laboratory effects or interference, special considerations, adverse effects or toxicity, patient assessments, and essential patient education.
An essential component of patient education is to ensure that individuals are informed about the timing, route, and dosage of oxycodone. Without proper information, patients may encounter significant issues related to their medication. A primary concern regarding the use of oxycodone is its potential for abuse. It is crucial to advise patients about this risk, emphasizing that oxycodone has known abuse potential. Patients should be instructed to secure their medication from theft and never to share it with others. Additionally, oxycodone should be stored out of reach of children and in a location not easily accessible to others (Vallerand, Sanoski, & Quiring, 2019). Educating patients about drug abuse and how to prevent it is a vital aspect of patient teaching. Furthermore, the resource detailing Xtampza ER oxycodone capsules indicates that the medication may cause fetal harm and should be avoided during pregnancy.
In summary, the oxycodone brochure is designed to provide essential information in an accessible format for non-medical individuals. This resource is intended to equip patients and their families with the knowledge needed to use the medication safely and effectively. Ensuring that patients are well-informed about oxycodone’s properties and the importance of responsible use will contribute to improved patient outcomes and minimize the risk of abuse.
Collegium Pharmaceutical, Inc. (n.d.). XTAMPZA ER- oxycodone capsule, extended release. Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2019). Davis’s drug guide for nurses. F. A. Davis Company.
Have a question or need support? Connect with our team today. We’re ready to assist you with personalized guidance to help you achieve your academic goals. Reach out via email, phone, or our easy-to-use contact form.
612-217-0144
info@hireonlineclasshelp.com
Get expert assistance to excel in your courses with personalized support. Our creative approach ensures your academic success every step of the way.
Our Services